Alteogen Inc. Alteogen Inc.

Alteogen Inc.

196170

Rank in Stocks #1916
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters,... ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial; and Biogen Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Share Price
$163.19
Market Cap
$11.36B
Change (1 day)
2.61%
Change (1 year)
-47.26%
Country
KR
Trade Alteogen Inc. (196170)

Category

Healthcare
Stock split history for Alteogen Inc. (196170)
Alteogen Inc. stock (symbol: 196170) underwent a total of 5 stock splits.
The most recent stock split occurred on Aug 05, 2026.
One 196170 share bought prior to Dec 07, 2017 would equal to 1.2037037037037 196170 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2026-08-05 13:10 x1.3 x1.2037037037037
2022-10-25 6:5 x1.2 x0.92592592592593
2021-03-24 5:4 x1.25 x0.77160493827161
2020-07-23 10:9 x1.1111111111111 x0.61728395061728
2017-12-07 5:9 x0.55555555555556 x0.55555555555556
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL